Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
E-Prescribing
Payers
DoseSpot study: Many patients are overpaying for GLP-1s
Concern about the cost of GLP-1s remains high, and a new study suggests it's not uncommon for patients to overpay for these drugs.
Paige Minemyer
Jun 23, 2025 6:00am
DEA, HHS delay effective date of virtual OUD prescribing rule
Feb 18, 2025 2:15pm
DEA proposes special registrations for telehealth prescribing
Jan 15, 2025 12:20pm
PE firm TPG Capital buys majority stake in Surescripts
Oct 2, 2024 7:30am
HIMSS24: Surescripts unveils data on interoperability gains
Mar 11, 2024 8:00am
Elation Health taps Surescripts to boost drug price transparency
Jan 25, 2024 4:00pm
